Pacific Biosciences of California PACB Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's investment proceeds?
- Pacific Biosciences of California (PACB) reported investment proceeds of $48.25M in Q1 2026.
- How has Pacific Biosciences of California's investment proceeds changed year-over-year?
- Pacific Biosciences of California's investment proceeds decreased by 57.5% year-over-year, from $113.44M to $48.25M.
- What is the long-term trend for Pacific Biosciences of California's investment proceeds?
- Over 2 years (2021 to 2025), Pacific Biosciences of California's investment proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $212.73M to $0.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.